Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290965 · ClinicalTrials.gov registry record · Phase 1
Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients
A Phase 1 study, sponsored by Scynexis.
- Completed
- Registry status
- Phase 1
- Development phase
- 57
- Enrollment target
NCT01290965 is a Phase 1 study that has completed, run by Scynexis. The registered enrollment target is 57 participants.
The verdict
NCT01290965, a Phase 1 study, has completed, sponsored by Scynexis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 57 participants
- Enrollment target
Study Summary
This study will examine the effectiveness of 15 days of therapy with SCY-635 in reducing hepatitis C virus (HCV) RNA levels.
Interventions
- DRUG Placebo
- DRUG SCY-635
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01290965
The ClinicalTrials.gov registry entry for NCT01290965 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scynexis, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01290965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01290965 about?
NCT01290965 is a clinical study titled "Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients". This study will examine the effectiveness of 15 days of therapy with SCY-635 in reducing hepatitis C virus (HCV) RNA levels.
What is the current status of trial NCT01290965?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2007-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT01290965?
The interventions under investigation include: Placebo (DRUG), SCY-635 (DRUG).
Who is sponsoring clinical trial NCT01290965?
This trial is sponsored by Scynexis, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.